‘, ‘
‘, ‘
Similar Posts
Debate Over Antidepressants: FDA role in suppressing damaging data – WSJ
WSJ: Debate Over Antidepressants: FDA role in suppressing damaging data Tue, 25 May 2004 How were drug manufacturers able to conceal vital evidence of harmful antidepressant drug effects? The answer is becoming clearer by the day: federal regulators and the psychiatrists who tested these drugs in clinical trials are invested…
Prologue – Selling sickness – Moynihan & Cassels
Prologue Selling sickness by Ray Moynihan and Alan Cassels Thirty years ago the head of one of the world’s best-known drug companies made some very candid comments. Close to retirement at the time, Merck’s aggressive chief executive Henry Gadsden told Fortune magazine of his distress that the company’s potential markets…
Harvard research in China: Open Letter to Pres. Summers
Harvard research in China: Open Letter to Pres. Summers Sat, 12 Apr 2003 On May 15, 2002, The Boston Globe reported that Lawrence Summers, the President of Harvard University, “expressed deep regret that a dozen Harvard-run genetic studies in China failed to give test subjects adequate information about potential pitfalls.”…
British Government Issues New Warnings Re: Use of antidepressant drugs for children
British Government Issues New Warnings Re: Use of antidepressant drugs for children Tue, 23 Sep 2003 related link: U.K. Government Document – New SSRI Warnings for Children In light of evidence from previously unexamined data from controlled clinical trials, the British Committee on Safety of Medicines (CSM), an arm of…
Infomail Archive 2005
Infomail 2005 News Stories on Human Research Protection and Commentary by Vera Hassner Sharav Subscribe to the AHRP infomail list Dec 16: Drugs, Devices & Doctors – NYT Paul Krugman Dec 11: Scientific Fraud & Corruption on Both sides of Atlantic: Merck / Proctor & Gamble Dec 11: Gov Accountability…
Bill Moyers: the Real Show…Congressional hearing was abruptly cancelled
Bill Moyers: the Real Show…Congressional hearing was abruptly cancelled Tue, 27 Jul 2004 Congressman Greenwoods’ retirement statement indicates that he had negotiated his contract with Biotechnology Industry Org–a company that represents the very industry he was in the middle of investigating–on Tuesday. http://www.house.gov/greenwood/press_releases/2004/pr040722.html Tuesday was the precise day that Greenwood…